These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25751765)

  • 21. CpG DNA as a vaccine adjuvant.
    Klinman DM
    Expert Rev Vaccines; 2003 Apr; 2(2):305-15. PubMed ID: 12899580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells.
    Hartmann G; Battiany J; Poeck H; Wagner M; Kerkmann M; Lubenow N; Rothenfusser S; Endres S
    Eur J Immunol; 2003 Jun; 33(6):1633-41. PubMed ID: 12778481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation.
    Duramad O; Fearon KL; Chang B; Chan JH; Gregorio J; Coffman RL; Barrat FJ
    J Immunol; 2005 May; 174(9):5193-200. PubMed ID: 15843514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of CpG DNA as a mucosal vaccine adjuvant.
    McCluskie MJ; Weeratna RD; Payette PJ; Davis HL
    Curr Opin Investig Drugs; 2001 Jan; 2(1):35-9. PubMed ID: 11527008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice.
    Liu Y; Luo X; Yang C; Yu S; Xu H
    Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of CpG oligodeoxynucleotides in veterinary species.
    Ioannou XP; Griebel P; Mena A; Gomis SM; Godson DL; Mutwiri G; Hecker R; Babiuk LA; van Drunen Littel-van den Hurk S
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):157-67. PubMed ID: 12954116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant effects of bacillus Calmette-Guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine.
    Guo YJ; Wu D; Wang KY; Sun SH
    Scand J Immunol; 2007 Dec; 66(6):619-27. PubMed ID: 18021362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PyNTTTTGT prototype oligonucleotide IMT504, a novel effective adjuvant of the FMDV DNA vaccine.
    Zhao G; Jin H; Li J; Su B; Du X; Kang Y; Wang X; Wang B
    Viral Immunol; 2009 Apr; 22(2):131-8. PubMed ID: 19327000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa.
    Cox E; Verdonck F; Vanrompay D; Goddeeris B
    Vet Res; 2006; 37(3):511-39. PubMed ID: 16611561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo.
    Cao D; Li H; Jiang Z; Cheng Q; Yang Z; Xu C; Cao G; Zhang L
    Int Immunopharmacol; 2011 Jun; 11(6):748-54. PubMed ID: 21310256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice.
    McCluskie MJ; Davis HL
    J Immunol; 1998 Nov; 161(9):4463-6. PubMed ID: 9794366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmacytoid dendritic cells alter the antitumor activity of CpG-oligodeoxynucleotides in a mouse model of lung carcinoma.
    Sorrentino R; Morello S; Luciano A; Crother TR; Maiolino P; Bonavita E; Arra C; Adcock IM; Arditi M; Pinto A
    J Immunol; 2010 Oct; 185(8):4641-50. PubMed ID: 20855872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single, low dose oral antigen exposure in newborn piglets primes mucosal immunity if administered with CpG oligodeoxynucleotides and polyphosphazene adjuvants.
    Pasternak JA; Ng SH; Wilson HL
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):211-21. PubMed ID: 25194591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of neonatal sublingual vaccination with native or denatured ovalbumin and adjuvant CpG or cholera toxin on systemic and mucosal immunity in mice.
    Huang CF; Wu TC; Chu YH; Hwang KS; Wang CC; Peng HJ
    Scand J Immunol; 2008 Nov; 68(5):502-10. PubMed ID: 18822109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro.
    Matsumoto K; Terakawa M; Fukuda S; Kato A; Toki S; Shinohara M; Wakiguchi H; Saito H
    Int Arch Allergy Immunol; 2006; 140 Suppl 1():42-50. PubMed ID: 16772726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
    Wedlock DN; Skinner MA; de Lisle GW; Vordermeier HM; Hewinson RG; Hecker R; van Drunen Littel-van den Hurk S; Babiuk LA; Buddle BM
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):53-63. PubMed ID: 15910992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
    Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
    Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.
    Alignani D; Maletto B; Liscovsky M; Rópolo A; Morón G; Pistoresi-Palencia MC
    J Leukoc Biol; 2005 Jun; 77(6):898-905. PubMed ID: 15758079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal adjuvants.
    Freytag LC; Clements JD
    Vaccine; 2005 Mar; 23(15):1804-13. PubMed ID: 15734046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.